Vaccine Business – Five minutes of fame or five-time Oscar winner?

11:05 AM - 11:50 AM (EDT), Tuesday, June 15, 2021
Search General Info
Search Education
Search Partnering Companies

Vaccines have gone from under the radar to everywhere in the mind of the public and many new vaccine business models have emerged from the COVID-19 era.  Is this a short “5 minutes of fame” for vaccines or can the business gain and sustain public interest and investor confidence over the long-term.  Panelists will discuss whether and how the vaccine business can rise to a different level of significance in the healthcare and investor communities. 

Executive Director
WomenLift Health
Global President, Vaccines
Pfizer Inc.
Chairman, President & CEO
GeoVax Labs, Inc
Director of Therapeutics Research, Diversified Biopharma
SVB Leerink